SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-14-000006
Filing Date
2014-05-01
Accepted
2014-05-01 13:51:25
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-3312014x10xq.htm 10-Q 688230
2 EXHIBIT 10.1 pcrx-33114xex101.htm EX-10.1 72441
3 EXHIBIT 31.1 pcrx-33114xex311.htm EX-31.1 14797
4 EXHIBIT 31.2 pcrx-33114xex312.htm EX-31.2 14799
5 EXHIBIT 32.1 pcrx-33114xex321.htm EX-32.1 5638
6 EXHIBIT 32.2 pcrx-33114xex322.htm EX-32.2 5541
  Complete submission text file 0001396814-14-000006.txt   5717201

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pcrx-20140331.xml EX-101.INS 858033
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20140331.xsd EX-101.SCH 40338
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20140331_cal.xml EX-101.CAL 72022
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20140331_def.xml EX-101.DEF 154196
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20140331_lab.xml EX-101.LAB 534661
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20140331_pre.xml EX-101.PRE 283465
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 14803915
SIC: 2834 Pharmaceutical Preparations